Epilepsy Intractable
34
4
6
10
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
1 terminated out of 34 trials
90.9%
+4.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (34)
Neuronal Mechanisms of Learning and Utilizing Abstract Representations
5-SENSE Score Validation Study
Pediatric Epilepsy
Localizing Epileptic Networks Using MRI and iEEG
Sleep Disruption Pattern - Epilepsy Monitoring Unit
Neuronal Mechanisms of Human Episodic Memory
Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs
National Study on the Interest of EEG-fMRI in the Presurgical Evaluation of Partial Epilepsies Drug
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
Neural Computations of Goal-directed Decision-making
TMS - Intracranial Electrodes
Contribution of Genetics, Non-invasive Methods and Neuropsychology in Focal Cryptogenic Epilepsies
Neural Mechanisms of Spatial Representations Beyond the Self
Memory Retrieval and Encoding Investigated by Neural Stimulation
The Mosaic Brain: a New Diagnostic Approach in Focal Epilepsies
Thermocoagulation in Drug Resistant Focal Epilepsy
Ketogenic Diet in Pediatric Intractable Epilepsy
Evaluation of Ketoflo
Multicenter Comparison of Interictal HFO as a Predictor of Seizure Freedom
ABI-009 (Nab-rapamycin) for Surgically-Refractory Epilepsy (RaSuRE)